Blackmagic Design just released DaVinci Resolve 20.2.2, a small but important maintenance update addressing playback, trimming, and metadata issues introduced in the previous 20.2 release. While this version adds no major new features, it refines…
Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized by a loss of tear film homeostasis, resulting in ocular discomfort, visual disturbance, and tear film instability.1 DED is one of the most common…
YouTube has been testing a new UI for its video player since the beginning of this year, which was available to limited users. But now the company has officially announced that the new video player with an updated design is rolling out…
Ashley Tellis, an Indian-origin foreign policy expert on US and South Asian affairs, was arrested over the weekend after more than a thousand pages of US top secret documents were allegedly found at his home.
Royal Mail has been fined £21m for missing its annual first- and second-class mail delivery targets, leading to millions of letters arriving late across the UK, the regulator Ofcom has said.
This represents the third-largest fine ever imposed by the UK communications watchdog.
Royal Mail delivered 77% of first class-mail and 92.5% of second-class mail on time during the 2024-25 financial year, Ofcom found. This was short of its respective 93% and 98.5% targets.
Ian Strawhorne, the director of enforcement at Ofcom, said: “Millions of important letters are arriving late, and people aren’t getting what they pay for when they buy a stamp.
“These persistent failures are unacceptable, and customers expect and deserve better. Royal Mail must rebuild consumers’ confidence as a matter of urgency. And that means making actual significant improvements, not more empty promises.”
skip past newsletter promotion
after newsletter promotion
In April this year the price of a first-class stamp rose again, up 5p to £1.70, while the cost of the second-class service rose by 2p to 87p.
Surveys of more than 1,000 Italian patients and clinicians uncover why oral steroid use remains widespread in asthma care, revealing gaps in guideline adherence, patient education, and access to advanced biologic therapies.
